Family history of myocardial infarction is a risk factor for venous thromboembolism among whites but not among blacks

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 4, 2013, Pages 410-417

  Mili, Fatima D ^a   Hooper, W Craig ^a   Lally, Cathy ^b   Austin, Harland ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

comorbid condition; epidemiology; ethnicity; family history; myocardial infarction; venous thrombosis

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FAMILY HISTORY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOPLASM; OBESITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; VENOUS THROMBOEMBOLISM;

COMORBID CONDITION; EPIDEMIOLOGY; ETHNICITY; FAMILY HISTORY; MYOCARDIAL INFARCTION; VENOUS THROMBOSIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY HEALTH; FEMALE; GEORGIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84879942451     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612448419     Document Type: Article

References (34)

1. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003 ; 348 (15). 1435-1441
2. Becattini C, Agnelli G, Prandoni P, et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J. 2005 ; 26 (1). 77-83
3. Jerjes-Sanchez C. Venous and arterial thrombosis: a continuous spectrum of the same disease?. European Heart J. 2005 ; 26 (1). 3-4
4. Hooper WC, Champney KP, Palmer SJ. Inflammatory biomarkers as possible diagnostic and prognostic determinants in ACS: implications of gender, hyperglycemia, and diabetes. Acute Coronary Syndr. 2005 ; 7 (1). 10-19
5. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005 ; 162 (10). 975-982
6. Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet. 2007 ; 370 (9601). 1773-1779
7. Spencer FA, Ginsberg JS, Chong A, Alter DA. The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction. J Thromb Haemost. 2008 ; 6 (9). 1507-1513
8. Mahmoodi BK, Gansevoort RT, Veeger NJGM, et al. Microalbuminuria and risk of venous thromboembolism. JAMA. 2009 ; 301 (17). 1790-1797
9. Green D. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism. Hematology Am Soc Hematol Educ Program. 2009 ;: 259-266
10. Jezovnik MK, Poredos P, Lusa L. Idiopathic venous thrombosis is associated with preclinical atherosclerosis. J Atheroscler Thromb. 2010 ; 17 (3). 304-311
11. Huerta C, Johansson S, Wallander M-A, Garcia Rodriguez LA. Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism. Thromb J. 2008 ; 6: 10-18
12. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010 ; 56 (1). 1-7
13. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism. A meta-analysis. Circulation. 2008 ; 117 (1). 93-102
14. Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010 ; 121 (17). 1896-1903
15. Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007 ; 262 (2). 157-172
16. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999 ; 353 (9165). 1649-1652
17. Festa A, D'Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes. Diabetes. 2002 ; 51 (4). 1131-1137
18. Bezemer ID, van der Meer FJM, Eikenboom JC, Rosendaal FR, Doggen CJM. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009 ; 169 (6). 610-615
19. Noboa S, Le Gal G, Lacut K, et al. Family history as a risk factor for venous thromboembolism. Thromb Res. 2008 ; 122 (5). 624-629
20. Heit JA, Beckman MG, Bockenstedt PL, et al. Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross sectional study. Am J Hematol. 2010 ; 85 (7). 467-471
21. Mili FD, Hooper WC, Lally C, Austin H. The impact of co-morbid conditions on family history of venous thromboembolism in Whites and Blacks. Thromb Res. 2011 ; 127 (4). 309-316
22. Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormers J, Hansen JB. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost. 2008 ; 6 (11). 1851-1857
23. Quist-Paulsen P, Naess IA, Cannegieter SC, Romundstad PR, Christiansen SC, Rosendaal FR, Hammerstrøm J. Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica. 2010 ; 95 (1). 119-125
24. Zöller B, Li X, Sundquist J, Sundquist K. Venous thromboembolism does not share strong familial susceptibility with coronary heart disease: a nationwide family study in Sweden. Eur Heart J. 2011 ; 32 (22). 2800-2805
25. Barrett-Connor E, Khaw K-T. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation. 1984 ; 69 (6). 1065-1069
26. Jousilahti P, Puska P, Vartiainen E, Pekkanen J, Tuomilehto J. Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. J Clin Epidemiol. 1996 ; 49 (5). 497-503
27. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost. 2003 ; 1 (1). 80-87
28. Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, Hooper WC. Sickle cell trait and the risk of venous thromboembolism among Blacks. Blood. 2007 ; 110 (3). 908-912
29. Austin H, Hooper WC, Lally C, et al. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Clin Epidemiol. 2000 ; 53 (10). 997-1001
30. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985 ; 122 (5). 904-914
31. Benichou J, Gail MH. Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. Biometrics. 1990 ; 46 (4). 991-1003
32. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics. 1993 ; 49 (3). 865-872
33. Alderman MH, Cohen HW, Madhavan S. Myocardial infarction in treated hypertensive patients. The paradox of lower incidence but higher mortality in young Blacks compared with Whites. Circulation. 2000 ; 101 (10). 1109-1114
34. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol. 1988 ; 128 (6). 1185-1197